Literature DB >> 2162468

Evaluation of the antiviral effect of synthetic oligopeptides whose sequences are derived from paramyxovirus F1 N termini.

N M Inocencio1, B Gotoh, T Toyoda, C Kitada, Y Nagai.   

Abstract

We examined the antiviral effects of three oligopeptides, carbobenzoxy(Z)-D-Phe-Ile-Gly, Z-D-Leu-Ile-Gly and Z-D-Phe-Phe-Gly, which mimic the N-terminal regions of F1 glycoproteins of two Newcastle disease virus strains (Miyadera and D26) and Sendai virus, respectively. Only one of these peptides, Z-D-Phe-Phe-Gly, significantly and with a similar potency inhibited viruses of homologous and heterologous F1 N-terminal sequences, suggesting no strict sequence requirement for inhibition. Furthermore, the enveloped RNA viruses of several different families showed essentially the same sensitivity to the three peptides as the paramyxoviruses, while a non-enveloped RNA virus was not susceptible to any of them. In addition, the Z-D-Phe-Phe-Gly peptides was effective only when the virus particles had been pretreated before infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2162468     DOI: 10.1007/BF00198529

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  17 in total

1.  Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1977-07-01       Impact factor: 3.616

2.  Antigenic mapping and functional analysis of the F protein of Newcastle disease virus using monoclonal antibodies.

Authors:  G Abenes; H Kida; R Yanagawa
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

3.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

4.  Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides.

Authors:  C D Richardson; A Scheid; P W Choppin
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

5.  Newcastle disease virus evolution. II. Lack of gene recombination in generating virulent and avirulent strains.

Authors:  T Toyoda; T Sakaguchi; H Hirota; B Gotoh; K Kuma; T Miyata; Y Nagai
Journal:  Virology       Date:  1989-04       Impact factor: 3.616

6.  Isolation and characterization of the measles virus F1 polypeptide: comparison with other paramyxovirus fusion proteins.

Authors:  T M Varsanyi; H Jörnvall; E Norrby
Journal:  Virology       Date:  1985-11       Impact factor: 3.616

7.  Molecular cloning and nucleotide sequence of P, M and F genes of Newcastle disease virus avirulent strain D26.

Authors:  H Sato; M Oh-hira; N Ishida; Y Imamura; S Hattori; M Kawakita
Journal:  Virus Res       Date:  1987-05       Impact factor: 3.303

8.  Binding of cholesterol and inhibitory peptide derivatives with the fusogenic hydrophobic sequence of F-glycoprotein of HVJ (Sendai virus): possible implication in the fusion reaction.

Authors:  K Asano; A Asano
Journal:  Biochemistry       Date:  1988-02-23       Impact factor: 3.162

9.  Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus.

Authors:  T Toyoda; T Sakaguchi; K Imai; N M Inocencio; B Gotoh; M Hamaguchi; Y Nagai
Journal:  Virology       Date:  1987-05       Impact factor: 3.616

10.  Effects of viral chemotherapeutic agents on membrane properties. Studies of cyclosporin A, benzyloxycarbonyl-D-Phe-L-Phe-Gly and amantadine.

Authors:  R M Epand; R F Epand; R C McKenzie
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.